Repatha™ will be the only PCSK9-inhibitor on the CVS/caremark commercial formularies
Provides members with access to high quality drug and helps clients better manage their specialty pharmacy spend
WOONSOCKET, RI, 2015-11-24 — /EPR Retail News/ — CVS Health (NYSE: CVS) announced today that Repatha™ (evolocumab) from Amgen Inc. will be added as the only PCSK9 inhibitor on…
WOONSOCKET, R.I., 2015-8-12— /EPR Retail News/ — CVS Health (NYSE: CVS) today announced the launch of ScriptSync™, a new pharmacy service that enables patients with multiple medications to pick up their eligible maintenance prescriptions in a monthly CVS/pharmacy visit.
In addition, patients or caregivers can manage their ScriptSync prescriptions 24/7 using innovative online support tools. By…